Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01136512 · ClinicalTrials.gov registry record
Metformin Use and Vitamin B12 Deficiency
A clinical trial, sponsored by Northwell Health.
- Completed
- Registry status
- 89
- Enrollment target
NCT01136512: Completed study, sponsored by Northwell Health.
NCT01136512 is a clinical trial that has completed, run by Northwell Health. The registered enrollment target is 89 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01136512 has completed, sponsored by Northwell Health.
- COMPLETED
- Registry status
- 89 participants
- Enrollment target
Study Summary
The primary objective is to determine the incidence of Vitamin B12 deficiency in patients on metformin therapy for diabetes.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 89 participants |
| Start Date | 2007-08 |
| Est. Completion | 2008-12 |
What the finished NCT01136512 record still lists
NCT01136512 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 89 participants, a relatively small participant target.
The record links to 0 conditions, and to 0 interventions.
NCT01136512 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01136512 about?
NCT01136512 is a clinical study titled "Metformin Use and Vitamin B12 Deficiency". The primary objective is to determine the incidence of Vitamin B12 deficiency in patients on metformin therapy for diabetes.
What is the current status of trial NCT01136512?
This trial is currently completed. The enrollment target is 89 participants. The study started on 2007-08. Estimated completion is 2008-12.
Who is sponsoring clinical trial NCT01136512?
This trial is sponsored by Northwell Health, which has 370 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03682289 · 89 participants · Phase 2
Ceralasertib (AZD6738) Alone and in Combination With Olaparib or Durvalumab in Patients With Solid Tumors
- NCT04787939 · 89 participants · NA
Early Feeding After Oral Cavity Reconstruction
- NCT05480449 · 89 participants · Phase 1
Autologous HuCART19 T Cells Manufactured Using the CliniMACS Prodigy Platform for Pediatric B-ALL (huCART19 Prodigy)
- NCT05604131 · 89 participants · Phase 2
Cardiac MRI-guided Deferiprone Therapy for Acute Myocardial Infarction Patients
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia